Category Archives: Public Policy

Latest From Public Policy

BIO’s Prometheus v. Mayo Amicus Brief Filed

prometheus

BIO filed an amicus brief in the Prometheus v. Mayo Clinic case.  In this case the Supreme Court is being asked to decide whether diagnostic and personalized medicine claims that depend on a correlation of observed phenomena should be excluded from the patent system at the outset, as patent-ineligible abstract ideas or “laws of nature.” BIO’s brief argues that these judicially-created exclusions from patent-eligibility have traditionally been used only under narrow circumstances, and that their Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , ,

IPCC Features Update on Patent Reform Implementation

Gongola_Janet

The BIO Intellectual Property Counsels Committee Fall Conference featured an update on the implementation of the Leahy-Smith America Invents Act by Janet Gongola, Associate Solicitor of the U.S. Patent and Trademark Office (PTO). Some provisions of the Leahy-Smith America Invents Act took effect immediately when it was signed into law in September. Ms. Gongola reported that of the 20 provisions that must be implemented by the PTO, eight have been implemented and another ten are Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

The Critical Importance of International Patent Protection for Small Businesses

Stanley Erck

As part of the implementation of the Leahy-Smith America Invents Act, the U.S. Patent and Trademark Office (PTO) recently held two public hearing on international patent protection.  Stanley C. Erck, President and CEO of Novavax, Inc., testified on behalf of BIO in support of an initiative to reduce filing and prosecution costs for international patent protection of biotech inventions. In his testimony, Mr. Erck explained the important role patents play in the biotechnology industry. The Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Commercialization and Job Creation in the Biotechnology Sector

Doug Crawford

It’s tough presenting programs on technology transfer because so much has already been said that it’s hard to find something new. However, that was not a problem this week in San Francisco at the BIO Technology Transfer Symposium. The Symposium began with an overview of the efforts by the Obama Administration to spur innovation including funding macro and micro grants to encourage the development of regional technology clusters, and proof of concept centers to help Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , ,

EU Stem Cell Patent Decision Hurts Science

Æ

A great article in the Economist titled European science stemmed addresses the recent and controversial decision by the European Court of Justice regarding the patentability of certain inventions derived from embryonic stem cells. ANY country, you might think, would relish being able to call itself the world’s leader in scientific research. America and Europe, however, seem to be in a bizarre parallel contest: which can make its scientists’ lives more difficult by imposing the most muddled Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , ,